Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Insulin-like Growth Factor-1 Deficiency”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Post-approval studies (Phase 4)UnknownNCT01052623
What this trial is testing

Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)

Who this might be right for
Ataxia TelangiectasiaGrowth Failure
Johann Wolfgang Goethe University Hospital 24
Large-scale testing (Phase 3)Study completedNCT00125164
What this trial is testing

Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency

Who this might be right for
Growth DisordersInsulin-Like Growth Factor-1 Deficiency
Ipsen 137
Not applicableEnded earlyNCT00747604
What this trial is testing

IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

Who this might be right for
Primary Insulin-like Growth Factor-1 Deficiency
Ipsen 1,378
Large-scale testing (Phase 3)Study completedNCT00125190
What this trial is testing

Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency

Who this might be right for
Insulin-Like Growth Factor-1 DeficiencyGrowth Disorders
Ipsen 45
Testing effectiveness (Phase 2)Ended earlyNCT00490100
What this trial is testing

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

Who this might be right for
Growth FailureX-linked Severe Combined Immunodeficiency (XSCID)Growth Hormone Resistence
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Ended earlyNCT00330668
What this trial is testing

Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency

Who this might be right for
Growth Disorders
Ipsen 114
Not applicableLooking for participantsNCT00903110
What this trial is testing

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Who this might be right for
IGF1 Deficiency
Esteve Pharmaceuticals, S.A. 500
Testing effectiveness (Phase 2)Ended earlyNCT00572156
What this trial is testing

RhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

Who this might be right for
Insulin-like Growth Factor-1 Deficiency
Ipsen 106